Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?Zacks Investment Research • 10/06/26
Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up24/7 Wall Street • 10/05/26
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to KnowZacks Investment Research • 09/18/26
Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher24/7 Wall Street • 09/17/26
Novavax, Inc. (NVAX) Presents at Citigroup's Biopharma Back to School Summit 2026 TranscriptSeeking Alpha • 09/10/26
Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor ConferenceMarketBeat • 09/10/26
Novavax, Inc. (NVAX) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference TranscriptSeeking Alpha • 09/09/26
Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story?24/7 Wall Street • 09/01/26
Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination SeasonPRNewsWire • 08/28/26
NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook RaisedZacks Investment Research • 08/07/26